Gregory Roufa & David Glowacki are Building Digital Group Therapeutics | Psychedelic Invest Podcast

Coherus and AbbVie settle Humira biosimilar dispute after Mark Cuban’s Cost Plus Drugs announcement

Biosimilars player Coherus Biosciences has patched things up with AbbVie after the pharma said Coherus violated its non-exclusive license to commercialize Yusimry, a biosimilar of

June 15, 2023

New drug could transform treatment of brain tumors in younger people

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

August 25, 2023

Bariatric Surgeries Decline as GLP-1s Use Rises, Impacting Hospital Margins

What You Should Know: – A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S.

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.